New drug ZE63-0302 tested in healthy volunteers for first time
Knowledge-focused
Completed
This study tested a new drug called ZE63-0302 in 82 healthy adults to see if it is safe and how the body handles it. Participants received either the drug or a placebo by mouth. The goal was to measure side effects and drug levels in the blood, not to treat any disease.
Phase: PHASE1 • Sponsor: Eilean Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC